Why I think these two FTSE 250 growth shares could be undervalued
Robert Stephens discusses the investment potential of two consumer goods companies amidst an uncertain period for the UK economy.
5 years ago
Equities
Hotel Chocolat – premium value worth paying
Hotel Chocolat is another ‘quality’ brand that has the potential to develop still further upon its UK success to date,…
5 years ago
Joules – clearly defying the High Street gloom
Joules, the premium lifestyle brand, has shown clearly that it is defying the gloom being endured elsewhere on the High…
5 years ago
Futura Medical – Exciting milestone approaches
On Wednesday 10th April Futura Medical will be announcing its results and will undoubtedly provide an update on a number of…
5 years ago
Bullish trading update for PCF Group
Lender PCF Group issued a bullish trading update at its AGM, with new business origination 78% ahead of the comparable…
5 years ago
2 online businesses with excellent growth prospects
Robert Stephens, CFA, discusses the investment potential of two digitally-focused stocks, Rightmove and Just Eat.
5 years ago
Accrol Group – Falling knife or recovery play?
Shares in toilet paper manufacturer Accrol have gone down the pan of late, but there could be recovery potential, argues…
5 years ago
Why investors keep toasting Diageo
Robert Stephens, CFA, argues that demand for Diageo’s alcoholic beverages may remain robust – even if the global growth outlook…
5 years ago
Is Unilever still a no-brainer for dividend investors?
Have impressive annualised returns left Unilever overvalued, or is the company still the ultimate no-brainer? John Kingham investigates.
5 years ago
Synnovia could pay off for patient investors
The recent price fall-back for shares in Synnovia gives patient investors an excellent buying opportunity, according to Mark Watson Mitchell.
5 years ago